XENE
Xenon Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$55.23
-2.67 ▼ -4.61%
🌙 3월 13일 5:54 PM ET (한국 3/14 06:54)
$55.64
+0.41 ▲ +0.74%
| Index | RUT | P/E | - | EPS (ttm) | -4.36 | Insider Own | 3.52% | Shs Outstand | 0.08B | Perf Week | 31.69% |
| Market Cap | 4.59B | Forward P/E | - | EPS next Y | 4.01% | Insider Trans | -11.67% | Shs Float | 0.08B | Perf Month | 29.16% |
| Enterprise Value | 4.05B | PEG | - | EPS next Q | -1.19 | Inst Own | 99.13% | Short Float | 6.89% | Perf Quarter | 27.14% |
| Income | -0.35B | P/S | 612.61 | EPS this Y | -10.78% | Inst Trans | 0.1% | Short Ratio | 4.4 | Perf Half Y | 48.39% |
| Sales | 0.01B | P/B | 7.6 | EPS next 5Y | 14.05% | ROA | -33.77% | Short Interest | 5.53M | Perf YTD | 23.23% |
| Book/sh | 7.27 | P/C | 8.37 | EPS past 3/5Y | -28.36% -40.02% | ROE | -51.76% | 52W High | -13.64% ($63.95) | Perf Year | 56.99% |
| Cash/sh | 6.6 | P/FCF | - | Sales past 3/5Y | -7.36% -25.26% | ROIC | -58.81% | 52W Low | 106.54% ($26.74) | Perf 3Y | 61.35% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -44.99% | Gross Margin | 66.09% | Volatility(W/M) | 7.08% 5.1% | Perf 5Y | 168.76% |
| Dividend TTM | - | EV/Sales | 540.49 | Sales Y/Y TTM | - | Oper. Margin | -4974.27% | ATR (14) | 3.4 | Perf 10Y | 637.39% |
| Dividend Ex-Date | - | Quick Ratio | 13.42 | EPS Q/Q | -56.77% | Profit Margin | -4612.13% | RSI (14) | 63.79 | Recom | 1.05 |
| Dividend Gr. 3/5Y | - | Current Ratio | 13.42 | Sales Q/Q | - | SMA20 | 17.5% ($47) | Beta | 0.82 | Target Price | $78.5 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2000000 | SMA50 | 25.9% ($43.87) | Rel Volume | 3.06 | Prev Close | $57.9 |
| Employees | 370 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -9.94% - | SMA200 | 41.42% ($39.05) | Avg Volume(3M) | 1.26M | Price | $55.23 |
| IPO | 2014/11/5 | Option/Short | Yes/Yes | Trades | 25992 | Volume | 3,850,002 | Change | -4.61% |
뉴스 로딩 중...